Search

Join Central Square's new Horror Book Club.

Join us at the Valente Branch for coffee and games. We have Scrabble, cribbage, cards, Bananagrams, chess, checkers, Boggle and more!

Registration helpful.

Mark your calendars for our fourth annual Festival! Immerse yourself in a week of free Arts and STEM programming!

Are you an intermediate or advanced sewer?

Are you interested in podcasting, audio production, or video production?

Come to the Library to create something special!

Music and a quiet atmosphere will allow group members to relax and get centered as they fill in the outlines of paper Mandalas with colored markers

Join artist Alie Reilinger, printer at Cambridge-based Albertine Press and owner of Yellow Leg Studios, for an afternoon of Valentine’s Day printmaking.

Free event at the Cambridge Public Library.

Free event at the Cambridge Public Library.

February selection: James by Percival Everett

Come on your own, with friends, or bring the whole family to the museum for a special week of programming.

Would you like to make your own vinyl signs, stickers, or images to transfer to T-shirts and other textiles?

February Selection - 

Darning is a fabric mending technique that involves reinforcing or re-weaving a portion of fabric by hand.

In this hands-on session, you'll learn the basics of knitting, including how to cast on, do the knit stitch, and cast off.

What's all this fuss about fermented foods?

Want to learn how to create custom clothing and other fiber projects with embroidered text?

Join us for an evening of board games.

Free event at the Cambridge Public Library.

Come get creative at Collins!

Are you an intermediate or advanced sewer?

Learn how to use our Epilog Zing—an industry-standard laser cutting machine.

In this 90-minute workshop, you'll learn the basics of sewing machine operation and safety.

Join us for a virtual Death Cafe - an evening of open, lively, and insightful discussion about death for adults aged 18 and older.

Heidi Greulich and Matthew Meyerson will describe the 20-year history of sevabertinib, a new lung cancer drug that blocks both EGFR and the related HER2 protein.